Licensing Red¢ç/ET¢ç Recombination

* 2019  ÀÌÈÄ Ãë±Þ ¾ÈÇÔ*

Gene Bridges GmbH owns the exclusive rights to Red/ET Recombination, a revolutionary DNA engineering technology. Gene Bridges issues licenses for the use of the Red/ET Recombination technology to commercial users. Licensing arrangements for Red/ET Recombination are provided as world-wide, non-exclusive sub-licenses.

6-Month Trial License

6-month trial licenses for EUR 3,500 are available for commercial parties wishing to test the technology.
Each license is provided with an attractive support package consisting of:
  • Control experiment and materials
  • Detailed protocols
  • All necessary sequence information
  • Latest Red/ET Recombination plasmids regularly updated and supplied to licensee
  • Red/ET Recombination proficient strains

Full License (standard format)

Gene Bridges can customize full licenses to include access to any combination of the following applications:
  • Research only
  • Cloning & Subcloning
  • Knock-out & Knock-in constructs
  • Transgenic constructs
  • Conditional Knock-outs
  • Viral engineering
  • Transgenic Plants
They can be tailored to fit your requirements.
 
For more information about the licensing of Red/ET Recombination, please contact licenses@genebridges.com
»ç¿ë Èıâ
»ç¿ëÈıⰡ ¾ø½À´Ï´Ù.
»ç¿ëÈıâ ÀÛ¼º
gototop